SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001140361-19-003478
Filing Date
2019-02-19
Accepted
2019-02-19 17:21:39
Documents
8

Document Format Files

Seq Description Document Type Size
1 425 s002621x16_425.htm 425 84348
2 s002621x16_image01.jpg GRAPHIC 35961
3 s002621x16_image02.jpg GRAPHIC 146279
4 s002621x16_image03.jpg GRAPHIC 265649
5 s002621x16_image04.jpg GRAPHIC 157862
6 s002621x16_image05.jpg GRAPHIC 43648
7 s002621x16_image06.jpg GRAPHIC 223429
8 s002621x16_image07.jpg GRAPHIC 56451
  Complete submission text file 0001140361-19-003478.txt   1366741
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filed by) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Subject) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-34912 | Film No.: 19616131
SIC: 2834 Pharmaceutical Preparations